Companies › SGMOQ

SANGAMO THERAPEUTICS INC (SGMOQ)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001001233 · EDGAR filings · Updated 2026-07-20

SANGAMO THERAPEUTICS INC (SGMOQ) has reported institutional ownership of 25.4%, with 112 institutional managers holding positions valued at $26.0M per the latest 13F reporting period. SEC filings include an active bankruptcy or receivership filing (8-K Item 1.03), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01).

Latest updates

• 2026-07-20 — Current report (8-K) filed
• 2026-07-01 — Current report (8-K) filed
• 2026-06-23 — Amended current report (8-K/A) filed
• 2026-06-23 — Current report (8-K) filed
• 2026-05-27 — Insider transaction reported (Form 4)
• 2026-05-27 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, SANGAMO THERAPEUTICS INC has 112 institutional holders and institutional ownership of 25.4%.

Insider activity

Insiders reported 56 transactions (0 buys, 0 sells) across 14 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

DOCGO INC (DCGO) · IMAGENEBIO INC (IMA) · STREAMEX (STEX) · SANARA MEDTECH INC (SMTI) · VERRICA PHARMACEUTICALS INC (VRCA) · LIPOCINE INC NEW (LPCN)